Imunon, Inc.

Ownership Transactions Reported by 15 Insiders

Symbol
IMNN on Nasdaq
Industry
Pharmaceutical Preparations
Location
997 Lenox Drive, Suite 100, Lawrenceville, New Jersey

There are no Buy or Sell transactions made by insiders since 7/8/2023

Imunon, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Robert W. Hooper Director Jun 13, 2022
Timothy J. Tumminello Controller Jun 13, 2022
Constantine J. Kardaras Chief Accounting Officer Jun 13, 2022
Pok Yu Augustine Chow Director Mar 17, 2023
Khursheed Anwer Chief Scientific Officer Jun 12, 2024
Corinne Le Goff President and CEO, Director Mar 17, 2023
Sebastien Hazard Chief Medical Officer Dec 7, 2023
Frederick J. Fritz Director Jun 12, 2024
Christine Pellizzari Director Jun 12, 2024
Donald P. Braun Director Jun 12, 2024
James E. Dentzer Director Jun 12, 2024
David Gaiero Chief Financial Officer Jun 1, 2024
Stacy Lindborg President and CEO, Director Jun 12, 2024
Jeffrey Wayne Church Cfo Mar 15, 2024
Michael H. Tardugno Executive Chairman of Board, Director Jun 12, 2024

Recent Insider Transactions by Companies or Individuals for Imunon, Inc.

Insider Class Transaction % Value $ Price $ Shares Shares Owned Date Ownership